Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Verastem
VSTM
$604M
| $1.39M | ﹤0.01% |
37,450
+2,363
| +7% | +$86.8K |
|
2777
Playboy Inc
PLBY
$149M
| $1.38M | ﹤0.01% |
58,380
+29,025
| +99% | +$780K |
|
2778
Veru
VERU
$46M
| $1.37M | ﹤0.01% |
16,068
+425
| +3% | +$33.7K |
|
|
EVLO
2779
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $1.37M | ﹤0.01% |
9,734
+125
| +1% | +$24.8K |
|
|
BRT
2780
BRT Apartments
BRT
$269M
| $1.36M | ﹤0.01% |
70,456
+20,289
| +40% | +$376K |
|
2781
Arlo Technologies
ARLO
$1.54B
| $1.36M | ﹤0.01% |
211,425
-347,169
| -62% | -$2.16M |
|
|
BGRY
2782
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $1.35M | ﹤0.01% |
+192,572
| New | +$1.65M |
|
2783
Blend Labs
BLND
$367M
| $1.35M | ﹤0.01% |
+100,251
| New | +$1.7M |
|
2784
Utah Medical Products
UTMD
$230M
| $1.35M | ﹤0.01% |
14,558
| – | – |
|
2785
i3 Verticals
IIIV
$325M
| $1.33M | ﹤0.01% |
54,965
+2,188
| +4% | +$63.1K |
|
2786
Design Therapeutics
DSGN
$901M
| $1.33M | ﹤0.01% |
90,521
+2,756
| +3% | +$45.8K |
|
2787
VistaGen Therapeutics
VTGN
$11.8M
| $1.33M | ﹤0.01% |
16,170
+358
| +2% | +$31.1K |
|
|
GOLD
2788
Gold.com Inc
GOLD
$1.27B
| $1.32M | ﹤0.01% |
44,114
+648
| +1% | +$16.4K |
|
2789
Amerant Bancorp
AMTB
$1.14B
| $1.32M | ﹤0.01% |
53,501
+205
| +0.4% | +$4.84K |
|
|
ACBI
2790
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $1.31M | ﹤0.01% |
49,389
-342
| -0.7% | -$8.34K |
|
2791
Evolus
EOLS
$530M
| $1.3M | ﹤0.01% |
170,965
+89,311
| +109% | +$924K |
|
2792
Akebia Therapeutics
AKBA
$241M
| $1.28M | ﹤0.01% |
443,958
-658,251
| -60% | -$1.88M |
|
|
DSPG
2793
DELISTED
DSP Group Inc
DSPG
| $1.27M | ﹤0.01% |
58,131
+810
| +1% | +$14.5K |
|
2794
Hingham Institution for Saving
HIFS
$686M
| $1.27M | ﹤0.01% |
3,762
-16
| -0.4% | -$5K |
|
2795
Standard BioTools
LAB
$294M
| $1.26M | ﹤0.01% |
191,465
+5,362
| +3% | +$35.3K |
|
|
BRY
2796
DELISTED
Berry Corp
BRY
| $1.26M | ﹤0.01% |
174,473
-294,354
| -63% | -$1.74M |
|
2797
Universal Logistics Holdings
ULH
$518M
| $1.26M | ﹤0.01% |
62,614
+61
| +0.1% | +$1.32K |
|
2798
Tidewater
TDW
$4.55B
| $1.25M | ﹤0.01% |
103,998
-176,898
| -63% | -$2.01M |
|
2799
Hackett Group
HCKT
$277M
| $1.25M | ﹤0.01% |
63,691
+167
| +0.3% | +$3.13K |
|
2800
Clearfield
CLFD
$390M
| $1.25M | ﹤0.01% |
28,256
+145
| +0.5% | +$6.09K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.